UNMASK Unraveling Parkinson´s disease diagnostic
- Coordinator
- Nova Id Fct - Associacao Para a Inovacao E Desenvolvimento Da Fct, Portugal
- Runs
- 1 July 2024 to 30 June 2026
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 2 organisations in 2 countries
- Type
- European Research Council grant
- Grant agreement
- 101158248
What the project is doing
In the project's own words, from its summary on CORDIS.
Parkinson´s disease (PD) is a progressive, chronic, and debilitating neurodegenerative disease for which there is no cure and no diagnostic test available. About 10 million people live with PD worldwide (1.2 million in Europe), and this number is expected to double by 2030 due to the aging population. PD has a high social and economic burden, and there is the need to improve PD timely detection and diagnosis, especially in young people.
UNMASK aims to validate the technological and business feasibility of the olfaction-inspired technology developed in the ERC Starting Grant SCENT by establishing the proof-of-concept for the non-invasive and fast PD diagnostics. To accomplish this, we will approach the project from both Technical and Business perspectives, with a perfect synergy between the research and business teams, and a close contact with clinical collaborators and stakeholders.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Nova Id Fct - Associacao Para a Inovacao E Desenvolvimento Da Fct | Caparica | Portugal | Coordinator |
| Day One Societa a Responsabilita Limitata | Roma Rm | Italy | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI